Showing 1 - 14 results of 14 for search 'Jean‐Jacques Body', query time: 0.05s Refine Results
  1. 1
    Phase I/III study to confirm bioequivalence and safe switching of proposed biosimilar denosumab in postmenopausal osteoporosis

    Phase I/III study to confirm bioequivalence and safe switching of proposed biosimilar denosumab in postmenopausal osteoporosis by Jean-Jacques Body, Christie Nie, Barbara Vogg, Richard Eastell

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

    Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion by Jean-Jacques Body, Roger von Moos, Daniela Niepel, Bertrand Tombal

    Published 2018-09-01
    Get full text
    Article
  3. 3
    Involvement of FXR in the OPG/RANKL pathway of breast and prostate cancer cells

    Involvement of FXR in the OPG/RANKL pathway of breast and prostate cancer cells by Lara Absil, Emilie Rigaux, Lionel Tafforeau, Jean-Jacques Body, Denis Nonclercq, Fabrice Journe

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer by Komal Waqas, Joana Lima Ferreira, Elena Tsourdi, Jean-Jacques Body, Peyman Hadji, M.C. Zillikens

    Published 2021-06-01
    Get full text
    Article
  5. 5
    Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

    Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts by Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean-Jacques Body, Fabrice Journé

    Published 2025-01-01
    Get full text
    Article
  6. 6
    Assessment of self-reported fractures: data from the FRISBEE cohort

    Assessment of self-reported fractures: data from the FRISBEE cohort by Felicia Baleanu, Michel Moreau, Virginie Kinnard, Laura Iconaru, Rafik Karmali, Serge Rozenberg, Michel Rubinstein, Marianne Paesmans, Pierre Bergmann, Jean-Jacques Body

    Published 2020-10-01
    Get full text
    Article
  7. 7
    Fracture distribution in elderly women: A FRISBEE sub-study

    Fracture distribution in elderly women: A FRISBEE sub-study by Aude Mugisha, Jean-Jacques Body, Virginie Kinnard, Laura Iconaru, Felicia Baleanu, Alexia Charles, Murielle Surquin, Rafik Karmali, Pierre Bergmann, Florence Benoit

    Published 2021-04-01
    Get full text
    Article
  8. 8
    MOF/Hip fracture ratio in a Belgian cohort of post-menopausal women (FRISBEE): Potential impact on the FRAX® score

    MOF/Hip fracture ratio in a Belgian cohort of post-menopausal women (FRISBEE): Potential impact on the FRAX® score by Aude Mugisha, Pierre Bergmann, Virginie Kinnard, Laura Iconaru, Felicia Baleanu, Alexia Charles, Murielle Surquin, Rafik Karmali, Florence Benoit, Jean-Jacques Body

    Published 2021-04-01
    Get full text
    Article
  9. 9
    Risk factors for imminent fractures: A substudy of the Frisbee cohort

    Risk factors for imminent fractures: A substudy of the Frisbee cohort by Laura Iconaru, Michel Moreau, Felicia Baleanu, Virginie Kinnard, Alexia Charles, Aude Mugisha, Murielle Surquin, Florence Benoit, Rafik Karmali, Marianne Paesmans, Jean-Jacques Body, Pierre Bergmann

    Published 2021-04-01
    Get full text
    Article
  10. 10
    Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study

    Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study by Roger von Moos, Jean-Jacques Body, Oliver Guenther, Evangelos Terpos, Yves Pascal Acklin, Jindrich Finek, João Pereira, Nikos Maniadakis, Guy Hechmati, Susan Talbot, Harm Sleeboom

    Published 2018-03-01
    Get full text
    Article
  11. 11
    Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort

    Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort by Felicia Baleanu, Laura Iconaru, Alexia Charles, Virginie Kinnard, Jean‐François Fils, Michel Moreau, Rafik Karmali, Murielle Surquin, Florence Benoit, Aude Mugisha, Marianne Paesmans, Michaël R Laurent, Pierre Bergmann, Jean‐Jacques Body

    Published 2021-09-01
    Get full text
    Article
  12. 12
    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club by Michaël R. Laurent, Michaël R. Laurent, Stefan Goemaere, Charlotte Verroken, Charlotte Verroken, Pierre Bergmann, Jean-Jacques Body, Olivier Bruyère, Etienne Cavalier, Serge Rozenberg, Bruno Lapauw, Bruno Lapauw, Evelien Gielen, Evelien Gielen

    Published 2022-06-01
    Get full text
    Article
  13. 13
    Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper

    Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper by Sébastien Thureau, Jean Christophe Faivre, Richard Assaker, Emmanuel Biver, Cyrille B. Confavreux, Françoise Debiais, Martine Duterque-Coquillaud, Francesco Giammarile, Dominique Heymann, Frédéric E. Lecouvet, Laetitia Morardet, Frederic Paycha, Jean-Jacques Body, Marie-Hélène Vieillard

    Published 2020-06-01
    Get full text
    Article
  14. 14
    Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

    Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ES... by Peyman Hadji, Matti S. Aapro, Jean-Jacques Body, Michael Gnant, Maria Luisa Brandi, Jean Yves Reginster, M. Carola Zillikens, Claus-C. Glüer, Tobie de Villiers, Rod Baber, G. David Roodman, Cyrus Cooper, Bente Langdahl, Santiago Palacios, John Kanis, Nasser Al-Daghri, Xavier Nogues, Erik Fink Eriksen, Andreas Kurth, Rene Rizzoli, Robert E. Coleman

    Published 2017-06-01
    Get full text
    Article

Search Tools: